This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Genmab A+s. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Maroeska Oudshoorn: Innovator in Human Antibodies
Introduction
Maroeska Oudshoorn is a prominent inventor based in Utrecht, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of two patents to his name, Oudshoorn's work is paving the way for advancements in therapeutic and diagnostic methods.
Latest Patents
Oudshoorn's latest patents focus on human antibodies against tissue factor. These patents disclose isolated human monoclonal antibodies that bind to human tissue factor (TF) and related antibody-based compositions and molecules. Additionally, the patents include pharmaceutical compositions comprising these antibodies, along with therapeutic and diagnostic methods for their use.
Career Highlights
Maroeska Oudshoorn is associated with Genmab AS, a leading biotechnology company known for its innovative approaches to antibody development. His work at Genmab has been instrumental in advancing the understanding and application of monoclonal antibodies in medicine.
Collaborations
Oudshoorn collaborates with notable colleagues, including Sandra Verploegen and David P E Satijn. These partnerships enhance the research and development efforts within the field of antibody-based therapies.
Conclusion
Maroeska Oudshoorn's contributions to the field of human antibodies exemplify the impact of innovative research in biotechnology. His patents and work at Genmab are significant steps toward improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile